Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Valerie K Pasche, MD
THERABIONIC INC.
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tampa General Hospital, Tampa General Cancer Center
Tampa, Florida, United States
Andreas Karachristos, MDNot, yet, recruiting - Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, Illinois, United States
Al Benson, MDNot, yet, recruiting - Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
Ravi Paluri, MDRecruiting - Oregon Health & Science University, Knight Cancer Institute
Portland, Oregon, United States
Adel Kardosh, MDNot, yet, recruiting - Thomas Jefferson University Hospital, Sidney Kimmel Cancer Center
Philadelphia, Pennsylvania, United States
James Posey, III, MDNot, yet, recruiting - Dhr Health Advanced Care Center, Dhr Oncology Institute
Edinburg, Texas, United States
Lee Drinkard, MDNot, yet, recruiting - University of Texas Health Science Center, Mays Cancer Center
San Antonio, Texas, United States
Sukeshi P Arora, MDNot, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2023
- Primary completion
- 30 Oct 2024
- Completion
- 30 Oct 2024
- Last update posted
- 28 Jun 2023
- Registered enrollment
- 166
- Registry id
- NCT04797884
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.